Gene content    
CTNNB1 ( by HUGO)
Catenin (Cadherin-Associated Protein), Beta 1, 88kDa
Oncogene
Catenin (Cadherin-Associated Protein)
Beta 1
88kDa
CTNNB
MRD19
Catenin (Cadherin-Associated Protein)
Beta 1 (88kD)
armadillo
Catenin Beta-1
Beta-catenin
NCBI: 3p21    Ensembl: 3p22.1
CTNB1_HUMANSize: 781 amino acidsMass: 85497 Da

  • Subunit: Two separate complex-associated pools are found in the cytoplasm. The majority is present as component of an E-cadherin/ catenin adhesion complex composed of at least E-cadherin/CDH1 and beta-catenin/CTNNB1, and possibly alpha-catenin/CTNNA1; the complex is located to adherens junctions. The stable association of CTNNA1 is controversial as CTNNA1 was shown not to bind to F-actin when assembled in the complex. Alternatively, the CTNNA1-containing complex may be linked to F-actin by other proteins such as LIMA1. Another cytoplasmic pool is part of a large complex containing AXIN1, AXIN2, APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its subsequent degradation by the proteasome. Wnt-dependent activation of DVL antagonizes the action of GSK3B. When GSK3B activity is inhibited the complex dissociates, CTNNB1 is dephosphorylated and is no longer targeted for destruction. The stabilized protein translocates to the nucleus, where it binds TCF/LEF-1 family members, TBP, BCL9, BCL9L and possibly also RUVBL1 and CHD8. Binds CTNNBIP and EP300. CTNNB1 forms a ternary complex with LEF1 and EP300 that is disrupted by CTNNBIP1 binding (By similarity). Interacts with TAX1BP3 (via the PDZ domain); this interaction inhibits the transcriptional activity of CTNNB1 (By similarity). Interacts with AJAP1, BAIAP1, CARM1, CTNNA3, CXADR and PCDH11Y. Binds SLC9A3R1. Interacts with GLIS2 and MUC1. Interacts with SLC30A9. Interacts with XIRP1 (By similarity). Interacts directly with AXIN1; the interaction is regulated by CDK2 phosphorylation of AXIN1 (By similarity). Interacts with SCRIB. Interacts with RAPGEF2 (By similarity). Interacts with PTPRU (via the cytoplasmic juxtamembrane domain). Interacts with EMD. Interacts with TNIK and TCF7L2. Interacts with SESTD1 and TRPC4. Interacts with CAV1. Interacts with TRPV4. The TRPV4 and CTNNB1 complex can interact with CDH1. Interacts with VCL (By similarity). Interacts with PTPRJ. Interacts with PKT7 and CDK2. Interacts with FAT1 (via the cytoplasmic domain) (By similarity). Interacts with NANOS1 and NDRG2. Interacts with isoform 1 of NEK2. Interacts with both isoform 1 and isoform 2 of CDK5. Interacts with PTK6. Interacts with SOX7; this interaction may lead to proteasomal degradation of active CTNNB1 and thus inhibition of Wnt/beta-catenin-stimulated transcription. Identified in a complex with HINT1 and MITF. Interacts with FHIT. The CTNNB1 and TCF7L2/TCF4 complex interacts with PML (isoform PML-4). Interacts with FERMT2. Identified in a complex with TCF7L2/TCF4 and FERMT2. May interact with P-cadherin/CDH3 Sequence caution: Sequence=BAB93475.1; Type=Erroneous initiation; Note=Translation N-terminally extended; Selected PDB 3D structures from [IMAGE] and Proteopedia [IMAGE] for CTNNB1 (see all 18): 1G3J (3D) [IMAGE] 1JDH (3D) [IMAGE] 1JPW (3D) [IMAGE] 1LUJ (3D) [IMAGE] 1P22 (3D) [IMAGE] 1QZ7 (3D) [IMAGE]
  • Tissue specificity: Expressed in several hair follicle cell types: basal and peripheral matrix cells, and cells of the outer and inner root sheaths. Expressed in colon. Present in cortical neurons (at protein level) [IMAGE] Pathway & Disease-focused RT2 Profiler PCR Arrays i
  • Function:
    UniProtKB/Swiss-Prot Summary: CTNB1_HUMAN, P35222 Function: Key downstream component of the canonical Wnt signaling pathway. In the absence of Wnt, forms a complex with AXIN1, AXIN2, APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its subsequent degradation by the proteasome. In the presence of Wnt ligand, CTNNB1 is not ubiquitinated and accumulates in the nucleus, where it acts as a coactivator for transcription factors of the TCF/LEF family, leading to activate Wnt responsive genes. Involved in the regulation of cell adhesion. Acts as a negative regulator of centrosome cohesion. Involved in the CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization. Blocks anoikis of malignant kidney and intestinal epithelial cells and promotes their anchorage-independent growth by down-regulating DAPK2. Disrupts PML function and PML-NB formation by inhibiting RANBP2-mediated sumoylation of PML
  • Similarity:
    Belongs to the beta-catenin family
                          
    Contains 12 ARM repeats [IMAGE]
  • Protein Domain/Family    
    Source ID Domain Name Type
    InterProIPR000225ArmadilloArmadilloRepeat
    IPR011989ARM-likeArmadillo-like helicalDomain
    BlocksIPB000225Armadillo repeatArmadillo repeat
    IPB000357HEAT repeatHEAT repeat

    Gene Ontology    
    Type Term Evidence Source Pub
    Biological Process androgen receptor signaling pathway NAS GOA 15572661
    canonical Wnt signaling pathway IDA GOA 12937339
    canonical Wnt signaling pathway involved in negative regulation of apoptotic process IMP GOA 12154096
    canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition IMP GOA 17072303
    cell adhesion IMP GOA 19101069
    cellular response to growth factor stimulus IMP GOA 16858403
    cellular response to indole-3-methanol IDA GOA 10868478
    epithelial to mesenchymal transition TAS GOA 14679171
    hair cell differentiation TAS GOA 19251162
    negative regulation of cell proliferation IDA GOA 12970740
    negative regulation of transcription, DNA-templated IMP GOA 19653274
    positive regulation of apoptotic process IDA GOA 12970740
    positive regulation of heparan sulfate proteoglycan biosynthetic process IMP GOA 15853773
    positive regulation of transcription from RNA polymerase II promoter IMP GOA 15592430
    positive regulation of transcription from RNA polymerase II promoter IDA GOA 11751639
    positive regulation of transcription, DNA-templated IMP GOA 12949260
    positive regulation of transcription, DNA-templated IDA GOA 12970740
    regulation of angiogenesis TAS GOA 18756595
    regulation of calcium ion import IDA GOA 19996314
    regulation of centriole-centriole cohesion IDA GOA 18086858
    regulation of fibroblast proliferation TAS GOA 16858403
    regulation of protein localization to cell surface IDA GOA 19996314
    regulation of smooth muscle cell proliferation IMP GOA 17122440
    response to drug IEP GOA 18291362
    response to estradiol IDA GOA 15304487
    single organismal cell-cell adhesion IMP GOA 18593713
    Wnt signaling pathway IDA GOA 10644691
    Cellular Component adherens junction IDA GOA 16858403
    beta-catenin destruction complex IDA GOA 16188939
    beta-catenin-TCF7L2 complex IDA GOA 9065401
    catenin complex IDA GOA 18593713
    cell cortex IDA GOA 19038973
    cell junction TAS GOA 17047063
    cell junction IDA GOA 19038973
    cell periphery IDA GOA 19038973
    cell-cell adherens junction IDA GOA 10403777
    cell-cell junction IDA GOA 19151727
    centrosome IDA GOA 18086858
    cytoplasm IDA GOA 11793365
    cytosol IDA GOA 10980594
    extracellular vesicular exosome IDA GOA 19199708
    lateral plasma membrane IDA GOA 12072559
    nucleus IDA GOA 10980594
    perinuclear region of cytoplasm IDA GOA 19038973
    protein-DNA complex IDA GOA 10825188
    transcription factor complex IDA GOA 11751639
    Molecular Function alpha-catenin binding IPI GOA 7650039
    androgen receptor binding NAS GOA 15572661
    cadherin binding IPI GOA 12734196
    enzyme binding IPI GOA 18356165
    estrogen receptor binding IPI GOA 15304487
    I-SMAD binding IPI GOA 18593713
    ion channel binding IPI GOA 19996314
    kinase binding IPI GOA 8638126
    nuclear hormone receptor binding TAS GOA 16344550
    nuclear hormone receptor binding IPI GOA 12799378
    protein binding IPI GOA 10773885
    protein C-terminus binding IPI GOA 10773885
    protein phosphatase binding IPI GOA 16574648
    signal transducer activity NAS GOA 10192393
    SMAD binding IPI GOA 18593713
    transcription coactivator activity IMP GOA 12949260
    transcription coactivator activity IDA GOA 11751639
    transcription factor binding TAS GOA 16344550
    transcription regulatory region DNA binding IDA GOA 18193033

    Disorder & Mutation    
    Source Disease
    SWISS-PROTNote=Activating mutations in CTNNB1 have oncogenic activity resulting in tumor development. Somatic mutations are found in various tumor types, including colon cancers, ovarian and prostate carcinomas, hepatoblastoma (HB), hepatocellular carcinoma (HCC). HBs are malignant embryonal tumors mainly affecting young children in the first three years of life
    SWISS-PROTColorectal cancer (CRC) [MIM:114500]: A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history. Note=The gene represented in this entry may be involved in disease pathogenesis
    SWISS-PROTPilomatrixoma (PTR) [MIM:132600]: Common benign skin tumor. Note=The disease is caused by mutations affecting the gene represented in this entry
    SWISS-PROTMedulloblastoma (MDB) [MIM:155255]: Malignant, invasive embryonal tumor of the cerebellum with a preferential manifestation in children. Note=The gene represented in this entry may be involved in disease pathogenesis
    SWISS-PROTOvarian cancer (OC) [MIM:167000]: The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry
    SWISS-PROTNote=A chromosomal aberration involving CTNNB1 is found in salivary gland pleiomorphic adenomas, the most common benign epithelial tumors of the salivary gland. Translocation t(3;8)(p21;q12) with PLAG1
    SWISS-PROTMesothelioma, malignant (MESOM) [MIM:156240]: An aggressive neoplasm of the serosal lining of the chest. It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. Note=The gene represented in this entry may be involved in disease pathogenesis

    CTNNB1 cross reference    
    PubMed OMIM Entrez Gene NCKU SNP Nucleotide UniProt Genome Data Viewer HomoloGene